Product Center

The BD ProbeTec™ ET System and the BD Viper™ System offer DNA amplification assays for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) for use in public health, physician office, reference and hospital clinical laboratories. These systems are state-of-the-art molecular technologies that are easy to use, have minimal hands-on time, and provide rapid results increasing laboratory efficiency at the most labor-intensive steps for molecular methods, sample handling, amplification and detection. The BD Affirm™ VPIII tests for the detection of Candida sp., Gardnerella vaginalis, and Trichomonas vaginalis translate the power and precision of RNA probe technology to aid better laboratory practice and patient care in an easy to use format.

The BD Max™ System is designed to reduce the time, complexity, and overall cost of molecular testing.

The BD Viper™ System with XTR™ technology provides the consistent, reliable performance that is sought after in the industry today:

• Fully automated specimen processing for all sample types provides maximum processing efficiency - up to 736 CT/GC results in an 8.5-hour shift.
• Least total hands-on time - thanks to ease-of-use and walk-away automation - delivers efficient workflows to maximize laboratory resources while producing high quality assay results you can trust.
• Total System Integrity assures reliability - in your system, in your reagents, in your results, and in your support.

With the BD Viper™ System with XTR™ technology, you can be sure your lab is achieving peak performance, reliably.

The Affirm™ VPIII Microbial Identification Test is the first direct specimen DNA probe-based diagnostic test for the differential detection and identification of the causative agents for vaginitis: Candida species, Gardnerella vaginalis and Trichomonas vaginalis.

The Affirm™ VPIII test’s DNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens. The test features an easy-to-read visible color reaction that is more accurate than current microscopic methods for detecting the causative agents of vaginitis. Additionally, its performance is unhampered by "difficult specimens," self-medication or the presence of mixed infections.

Total time-to-results is under 45 minutes, with less than 2 minutes hands-on time needed. The simple, automated procedure can be performed with minimal training.

The BD ProbeTec™ ET System is the first real-time DNA amplification assay for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in clinical specimens.

Based on proprietary BD technology, Strand Displacement Amplification (SDA) and real-time homogeneous detection, the system design combines short time-to-results, minimal labor, high throughput and ease-of-use to make the BD ProbeTec ET System the choice for laboratories throughout the world.

(BD ProbeTec™ Q^x Amplified DNA Assays used with the BD Viper™ System with XTR™ Technology are located here.)

BD Diagnostics Infectious Disease offers diagnostic products that provide laboratories with the capability to deliver critical, relevant information in a timeframe that enables significantly earlier clinical decisions.